Zacks Investment Management »

Supernus Pharmaceuticals shares owned by Zacks Investment Management

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Zacks Investment Management from 13F filings

Historical chart of Zacks Investment Management investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Zacks Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Zacks Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.8M 36k 49.70
2021-12-31 $834k 29k 29.17

More positions owned by Zacks Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Caterpillar (CAT)
JPMorgan Chase & Co. (JPM)
Wal-Mart Stores (WMT)
Exxon Mobil Corporation (XOM)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Amazon (AMZN)
Johnson & Johnson (JNJ)
Parker-Hannifin Corporation (PH)
Cisco Systems (CSCO)
Abbvie (ABBV)

View all positions for Zacks Investment Management

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Millennium Management
Vanguard Portfolio Management
Vanguard Capital Management
Dimensional Fund Advisors
State Street Corporation
Nomura Asset Management International
Armistice Capital
Renaissance Technologies
Geode Capital Management
Citadel Advisors
Loomis, Sayles and
Stephens Investment Management Group
Point72 Asset Management

View all funds holding Supernus Pharmaceuticals